Vault-13

MONTANOVA CAPITAL, LLC

New York, NY · CIK 1569064 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2014 · limited liability company

$4.8bn reported value +29.0% vs Q1 2026
95positions
44.6%in top 10
21 new 25 added 17 reduced 14 sold out vs Q1 2026

Options: 0 call positions (— notional), 1 put positions ($709.4m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERADERMICS INC COMMON STOCK MANE MANE 4,168,970 $512.5m10.77% 10.77% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.2m, Q2 2026 4.2m
2 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 12,437,000 $326.1m6.85% 6.85% AddedShares held: Q3 2025 10.5m, Q4 2025 12.0m, Q1 2026 12.3m, Q2 2026 12.4m +110.0k +110,000 0.9%
3 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 7,070,000 $204.2m4.29% 4.29% ReducedShares held: Q3 2025 3.8m, Q4 2025 6.6m, Q1 2026 7.6m, Q2 2026 7.1m -511.0k -511,029 -6.7%
4 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 1,135,406 $173.5m3.65% 3.65% ReducedShares held: Q3 2025 822.4k, Q4 2025 892.4k, Q1 2026 1.2m, Q2 2026 1.1m -18.1k -18,090 -1.6%
5 ARRIVENT BIOPHARMA INC COM AVBP AVBP 4,515,531 $156.9m3.30% 3.30% AddedShares held: Q3 2025 3.7m, Q4 2025 4.1m, Q1 2026 4.4m, Q2 2026 4.5m +114.4k +114,448 2.6%
6 BENITEC BIOPHARMA INC COM NEW BNTC BNTC 11,548,351 $154.5m3.25% 3.25% UnchangedShares held: Q3 2025 9.9m, Q4 2025 11.5m, Q1 2026 11.5m, Q2 2026 11.5m
7 BIOHAVEN LTD COM BHVN BHVN 10,286,937 $153.1m3.22% 3.22% UnchangedShares held: Q3 2025 5.6m, Q4 2025 10.3m, Q1 2026 10.3m, Q2 2026 10.3m
8 ADVANCED MICRO DEVICES INC COM AMD AMD 257,240 $149.4m3.14% 3.14% UnchangedShares held: Q3 2025 398.8k, Q4 2025 389.6k, Q1 2026 257.2k, Q2 2026 257.2k
9 ARCUS BIOSCIENCES INC COM RCUS RCUS 4,776,423 $147.3m3.09% 3.09% ReducedShares held: Q3 2025 3.7m, Q4 2025 5.2m, Q1 2026 5.0m, Q2 2026 4.8m -254.6k -254,570 -5.1%
10 TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS TSM TSM 304,627 $145.5m3.06% 3.06% AddedShares held: Q3 2025 277.2k, Q4 2025 271.4k, Q1 2026 298.7k, Q2 2026 304.6k +5.9k +5,920 2.0%
11 NVIDIA CORPORATION COM NVDA NVDA 720,609 $144.2m3.03% 3.03% AddedShares held: Q3 2025 483.5k, Q4 2025 530.9k, Q1 2026 574.7k, Q2 2026 720.6k +146.0k +145,953 25.4%
12 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 8,296,375 $118.6m2.49% 2.49% UnchangedShares held: Q3 2025 6.2m, Q4 2025 7.8m, Q1 2026 8.3m, Q2 2026 8.3m
13 SYSCO CORP COM SYY SYY 1,411,550 $118.0m2.48% 2.48% AddedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.2m, Q2 2026 1.4m +252.4k +252,394 21.8%
14 GE AEROSPACE COM NEW GE GE 310,262 $116.0m2.44% 2.44% UnchangedShares held: Q3 2025 310.3k, Q4 2025 310.3k, Q1 2026 310.3k, Q2 2026 310.3k
15 IMMATICS N.V SHS IMTX IMTX 11,190,129 $113.4m2.38% 2.38% UnchangedShares held: Q3 2025 12.0m, Q4 2025 11.2m, Q1 2026 11.2m, Q2 2026 11.2m
16 MGM RESORTS INTERNATIONAL COM MGM MGM 2,325,360 $111.2m2.34% 2.34% AddedShares held: Q3 2025 0, Q4 2025 1.2m, Q1 2026 2.2m, Q2 2026 2.3m +166.6k +166,560 7.7%
17 META PLATFORMS INC CL A META META 175,807 $99.0m2.08% 2.08% AddedShares held: Q3 2025 171.0k, Q4 2025 169.1k, Q1 2026 169.7k, Q2 2026 175.8k +6.1k +6,100 3.6%
18 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 4,092,784 $98.6m2.07% 2.07% AddedShares held: Q3 2025 0, Q4 2025 1.8m, Q1 2026 3.8m, Q2 2026 4.1m +274.2k +274,184 7.2%
19 KURA ONCOLOGY INC COM KURA KURA 8,575,422 $94.1m1.98% 1.98% UnchangedShares held: Q3 2025 8.1m, Q4 2025 8.6m, Q1 2026 8.6m, Q2 2026 8.6m
20 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 3,549,539 $85.9m1.81% 1.81% ReducedShares held: Q3 2025 3.4m, Q4 2025 3.4m, Q1 2026 4.2m, Q2 2026 3.5m -677.3k -677,270 -16.0%
21 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 2,503,109 $82.4m1.73% 1.73% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.5m
22 HOME DEPOT INC COM HD HD 226,053 $79.7m1.68% 1.68% AddedShares held: Q3 2025 197.3k, Q4 2025 240.9k, Q1 2026 221.6k, Q2 2026 226.1k +4.5k +4,463 2.0%
23 HUT 8 CORP COM HUT HUT 670,000 $77.3m1.63% 1.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 670.0k
24 CAPITAL ONE FINL CORP COM COF COF 333,098 $66.8m1.40% 1.40% AddedShares held: Q3 2025 238.8k, Q4 2025 172.0k, Q1 2026 302.4k, Q2 2026 333.1k +30.7k +30,698 10.2%
25 VULCAN MATLS CO COM VMC VMC 214,978 $63.4m1.33% 1.33% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 181.6k, Q2 2026 215.0k +33.4k +33,384 18.4%
26 FERGUSON ENTERPRISES INC COMMON STOCK NEW FERG FERG 246,758 $58.6m1.23% 1.23% AddedShares held: Q3 2025 306.3k, Q4 2025 159.2k, Q1 2026 211.9k, Q2 2026 246.8k +34.9k +34,858 16.4%
27 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 9,443,001 $55.7m1.17% 1.17% AddedShares held: Q3 2025 5.5m, Q4 2025 5.6m, Q1 2026 9.1m, Q2 2026 9.4m +376.0k +376,000 4.2%
28 INFLARX NV COM IFRX IFRX 22,933,910 $51.4m1.08% 1.08% AddedShares held: Q3 2025 6.5m, Q4 2025 7.9m, Q1 2026 7.9m, Q2 2026 22.9m +15.0m +15,000,000 189.1%
29 AURA BIOSCIENCES INC COM AURA AURA 7,206,217 $51.2m1.08% 1.08% AddedShares held: Q3 2025 4.4m, Q4 2025 4.4m, Q1 2026 4.4m, Q2 2026 7.2m +2.8m +2,833,333 64.8%
30 FAETH THERAPEUTICS INC COM NEW FTH FTH 2,020,103 $50.5m1.06% 1.06% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 34.5k, Q2 2026 2.0m +2.0m +1,985,554 5747.1%
31 ADVISORSHARES TR PURE US CANNABIS MSOS MSOS 9,738,524 $49.5m1.04% 1.04% AddedShares held: Q3 2025 7.2m, Q4 2025 8.7m, Q1 2026 9.0m, Q2 2026 9.7m +692.3k +692,324 7.7%
32 AMAZON COM INC COM AMZN AMZN 204,860 $48.8m1.03% 1.03% ReducedShares held: Q3 2025 218.5k, Q4 2025 406.1k, Q1 2026 254.0k, Q2 2026 204.9k -49.1k -49,149 -19.4%
33 REPLIMUNE GROUP INC COM REPL REPL 4,389,836 $48.6m1.02% 1.02% AddedShares held: Q3 2025 0, Q4 2025 36.0k, Q1 2026 4.2m, Q2 2026 4.4m +168.0k +168,000 4.0%
34 AMPHENOL CORP CL A APH APH 269,300 $47.5m1.00% 1.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 269.3k
35 SPOTIFY TECHNOLOGY S A SHS SPOT SPOT 101,800 $46.7m0.98% 0.98% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1k, Q2 2026 101.8k +100.7k +100,700 9154.5%
36 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 2,841,334 $46.6m0.98% 0.98% UnchangedShares held: Q3 2025 1.7m, Q4 2025 2.8m, Q1 2026 2.8m, Q2 2026 2.8m
37 APOLLO GLOBAL MGMT INC COM APO APO 383,300 $45.3m0.95% 0.95% ReducedShares held: Q3 2025 431.3k, Q4 2025 542.9k, Q1 2026 387.7k, Q2 2026 383.3k -4.4k -4,400 -1.1%
38 BANK AMERICA CORP COM BAC BAC 789,720 $45.0m0.95% 0.95% ReducedShares held: Q3 2025 1.2m, Q4 2025 1.5m, Q1 2026 1.3m, Q2 2026 789.7k -505.5k -505,525 -39.0%
39 ROUNDHILL ETF TRUST MEMORY ETF DRAM DRAM 603,000 $44.5m0.94% 0.94% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 603.0k
40 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,186,279 $44.4m0.93% 0.93% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.2m +142.4k +142,400 13.6%
41 CEREBRAS SYSTEMS INC COM CL A CBRS CBRS 171,900 $38.0m0.80% 0.80% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 171.9k
42 DICKS SPORTING GOODS INC COM DKS DKS 151,320 $34.3m0.72% 0.72% NewShares held: Q3 2025 128.3k, Q4 2025 114.3k, Q1 2026 0, Q2 2026 151.3k
43 BROADCOM INC COM AVGO AVGO 83,600 $31.6m0.66% 0.66% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 83.6k
44 COMPASS THERAPEUTICS INC COM CMPX CMPX 14,101,159 $30.9m0.65% 0.65% ReducedShares held: Q3 2025 14.1m, Q4 2025 14.2m, Q1 2026 14.3m, Q2 2026 14.1m -206.2k -206,220 -1.4%
45 LEXEO THERAPEUTICS INC COM LXEO LXEO 6,384,200 $29.7m0.62% 0.62% AddedShares held: Q3 2025 0, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 6.4m +5.1m +5,134,200 410.7%
46 UNITEDHEALTH GROUP INC COM UNH UNH 64,130 $26.7m0.56% 0.56% ReducedShares held: Q3 2025 96.2k, Q4 2025 111.3k, Q1 2026 100.6k, Q2 2026 64.1k -36.5k -36,500 -36.3%
47 PROKIDNEY CORP SHS CL A PROK PROK 12,341,266 $25.2m0.53% 0.53% UnchangedShares held: Q3 2025 12.3m, Q4 2025 12.3m, Q1 2026 12.3m, Q2 2026 12.3m
48 AADI BIOSCIENCE INC COM WHWK WHWK 4,300,000 $19.7m0.41% 0.41% AddedShares held: Q3 2025 3.7m, Q4 2025 3.7m, Q1 2026 3.7m, Q2 2026 4.3m +600.0k +600,000 16.2%
49 SPACE EXPLORATION TECHN CORP CLASS A COM STK SPCX SPCX 101,200 $17.3m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 101.2k
50 MARTIN MARIETTA MATLS INC COM MLM MLM 26,000 $15.0m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 26.0k
51 FULCRUM THERAPEUTICS INC COM FULC FULC 3,680,921 $13.5m0.28% 0.28% ReducedShares held: Q3 2025 5.4m, Q4 2025 6.6m, Q1 2026 6.6m, Q2 2026 3.7m -2.9m -2,880,190 -43.9%
52 PLANET FITNESS INC CL A PLNT PLNT 219,910 $11.5m0.24% 0.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 219.9k
53 BLOOM ENERGY CORP COM CL A BE BE 33,800 $10.2m0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 33.8k
54 KARDIGAN INC COM KARD KARD 400,000 $9.5m0.20% 0.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
55 CVS HEALTH CORP COM CVS CVS 84,500 $8.7m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 84.5k
56 MOLECULAR PARTNERS AG ADS MOLN MOLN 2,221,494 $8.6m0.18% 0.18% UnchangedShares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 2.2m, Q2 2026 2.2m
57 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 850,000 $8.4m0.18% 0.18% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 850.0k, Q2 2026 850.0k
58 DEXCOM INC COM DXCM DXCM 101,980 $6.9m0.14% 0.14% AddedShares held: Q3 2025 31.7k, Q4 2025 31.7k, Q1 2026 31.7k, Q2 2026 102.0k +70.3k +70,300 221.9%
59 THERMO FISHER SCIENTIFIC INC COM TMO TMO 13,400 $6.7m0.14% 0.14% UnchangedShares held: Q3 2025 13.4k, Q4 2025 13.4k, Q1 2026 13.4k, Q2 2026 13.4k
60 CENTENE CORP DEL COM CNC CNC 99,100 $6.4m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 99.1k
61 ABBOTT LABS COM ABT ABT 66,920 $6.1m0.13% 0.13% UnchangedShares held: Q3 2025 51.0k, Q4 2025 51.0k, Q1 2026 66.9k, Q2 2026 66.9k
62 BOSTON SCIENTIFIC CORP COM BSX BSX 140,083 $6.0m0.13% 0.13% AddedShares held: Q3 2025 353.6k, Q4 2025 353.6k, Q1 2026 123.9k, Q2 2026 140.1k +16.1k +16,142 13.0%
63 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 13,600 $5.4m0.11% 0.11% AddedShares held: Q3 2025 5.2k, Q4 2025 5.2k, Q1 2026 11.3k, Q2 2026 13.6k +2.3k +2,300 20.4%
64 DANAHER CORPORATION COM DHR DHR 26,600 $5.1m0.11% 0.11% ReducedShares held: Q3 2025 255.8k, Q4 2025 244.3k, Q1 2026 36.4k, Q2 2026 26.6k -9.8k -9,780 -26.9%
65 MINERALYS THERAPEUTICS INC COM MLYS MLYS 173,886 $4.7m0.10% 0.10% ReducedShares held: Q3 2025 2.1m, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 173.9k -1.4m -1,364,776 -88.7%
66 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 121,297 $4.5m0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 121.3k
67 SATELLOS BIOSCIENCE INC COM MSLE MSLE 475,000 $3.7m0.08% 0.08% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 475.0k, Q2 2026 475.0k
68 CENCORA INC COM COR COR 12,488 $3.5m0.07% 0.07% UnchangedShares held: Q3 2025 12.5k, Q4 2025 12.5k, Q1 2026 12.5k, Q2 2026 12.5k
69 TRULIEVE CANNABIS CORP SUB VTG SHS SUB VTG SHS 356,100 $3.5m0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 356.1k
70 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 500,000 $3.1m0.06% 0.06% ReducedShares held: Q3 2025 2.7m, Q4 2025 2.7m, Q1 2026 2.7m, Q2 2026 500.0k -2.2m -2,176,000 -81.3%
71 NATERA INC COM NTRA NTRA 10,100 $2.7m0.06% 0.06% UnchangedShares held: Q3 2025 10.1k, Q4 2025 10.1k, Q1 2026 10.1k, Q2 2026 10.1k
72 JOHNSON & JOHNSON COM JNJ JNJ 7,700 $2.0m0.04% 0.04% ReducedShares held: Q3 2025 132.8k, Q4 2025 98.8k, Q1 2026 23.4k, Q2 2026 7.7k -15.7k -15,700 -67.1%
73 LAM RESEARCH CORP COM NEW LRCX LRCX 4,302 $1.9m0.04% 0.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.3k
74 MICROSOFT CORP COM MSFT MSFT 4,970 $1.9m0.04% 0.04% UnchangedShares held: Q3 2025 109.5k, Q4 2025 159.7k, Q1 2026 5.0k, Q2 2026 5.0k
75 STRYKER CORPORATION COM SYK SYK 5,860 $1.8m0.04% 0.04% UnchangedShares held: Q3 2025 5.9k, Q4 2025 5.9k, Q1 2026 5.9k, Q2 2026 5.9k
76 EDWARDS LIFESCIENCES CORP COM EW EW 18,700 $1.7m0.04% 0.04% UnchangedShares held: Q3 2025 11.1k, Q4 2025 11.1k, Q1 2026 18.7k, Q2 2026 18.7k
77 MEDLINE INC COM CL A MDLN MDLN 42,500 $1.7m0.04% 0.04% UnchangedShares held: Q3 2025 0, Q4 2025 42.5k, Q1 2026 42.5k, Q2 2026 42.5k
78 PERFORMANCE FOOD GROUP CO COM PFGC PFGC 14,710 $1.6m0.03% 0.03% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 386.9k, Q2 2026 14.7k -372.2k -372,175 -96.2%
79 SNOWFLAKE INC CL A SNOW SNOW 5,600 $1.4m0.03% 0.03% NewShares held: Q3 2025 89.2k, Q4 2025 0, Q1 2026 0, Q2 2026 5.6k
80 IQVIA HLDGS INC COM IQV IQV 7,175 $1.4m0.03% 0.03% UnchangedShares held: Q3 2025 7.2k, Q4 2025 7.2k, Q1 2026 7.2k, Q2 2026 7.2k
81 MCKESSON CORP COM MCK MCK 1,830 $1.4m0.03% 0.03% UnchangedShares held: Q3 2025 1.8k, Q4 2025 1.8k, Q1 2026 1.8k, Q2 2026 1.8k
82 HCA HEALTHCARE INC COM HCA HCA 3,190 $1.2m0.03% 0.03% UnchangedShares held: Q3 2025 3.2k, Q4 2025 3.2k, Q1 2026 3.2k, Q2 2026 3.2k
83 WATERS CORP COM WAT WAT 3,225 $1.2m0.03% 0.03% UnchangedShares held: Q3 2025 3.1k, Q4 2025 3.1k, Q1 2026 3.2k, Q2 2026 3.2k
84 ALPHABET INC CAP STK CL C GOOG GOOG 3,400 $1.2m0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.4k
85 GRAINGER W W INC COM GWW GWW 770 $1.0m0.02% 0.02% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0k, Q2 2026 770 -230 -230 -23.0%
86 IONIS PHARMACEUTICALS INC COM IONS IONS 10,800 $856.3k0.02% 0.02% UnchangedShares held: Q3 2025 10.8k, Q4 2025 10.8k, Q1 2026 10.8k, Q2 2026 10.8k
87 US FOODS HLDG CORP COM USFD USFD 6,920 $707.6k0.01% 0.01% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 396.0k, Q2 2026 6.9k -389.1k -389,050 -98.2%
88 AGILENT TECHNOLOGIES INC COM A A 4,990 $662.8k0.01% 0.01% UnchangedShares held: Q3 2025 5.0k, Q4 2025 5.0k, Q1 2026 5.0k, Q2 2026 5.0k
89 VERALTO CORP COM SHS VLTO VLTO 5,475 $485.5k0.01% 0.01% UnchangedShares held: Q3 2025 5.5k, Q4 2025 5.5k, Q1 2026 5.5k, Q2 2026 5.5k
90 RESMED INC COM RMD RMD 2,390 $465.8k0.01% 0.01% UnchangedShares held: Q3 2025 2.4k, Q4 2025 2.4k, Q1 2026 2.4k, Q2 2026 2.4k
91 STERIS PLC SHS USD STE STE 1,530 $322.2k0.01% 0.01% UnchangedShares held: Q3 2025 1.5k, Q4 2025 1.5k, Q1 2026 1.5k, Q2 2026 1.5k
92 SAREPTA THERAPEUTICS INC COM SRPT SRPT 17,888 $321.4k0.01% 0.01% UnchangedShares held: Q3 2025 17.9k, Q4 2025 17.9k, Q1 2026 17.9k, Q2 2026 17.9k
93 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 3,260 $280.7k0.01% 0.01% UnchangedShares held: Q3 2025 3.3k, Q4 2025 3.3k, Q1 2026 3.3k, Q2 2026 3.3k
94 CHARLES RIV LABS INTL INC COM CRL CRL 1,010 $229.1k0.00% 0.00% NewShares held: Q3 2025 0, Q4 2025 1.0k, Q1 2026 0, Q2 2026 1.0k
95 INMED PHARMACEUTICALS INC COM NEW INM INM 100,000 $155.0k0.00% 0.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
APELLIS PHARMACEUTICALS INC APLS APLS 3,518,471 $141.5m3.5m shares
KALVISTA PHARMACEUTICALS INC KALV KALV 4,768,712 $96.0m4.8m shares
ERASCA INC ERAS ERAS 3,434,967 $55.6m3.4m shares
LIFE TIME GROUP HOLDINGS INC LTH LTH 510,349 $13.7m510.3k shares
WINGSTOP INC WING WING 59,500 $9.2m59.5k shares
COHERENT CORP COHR COHR 30,000 $7.1m30.0k shares
MEDTRONIC PLC MDT MDT 72,260 $6.3m72.3k shares
KEZAR LIFE SCIENCES INC KZR KZR 716,759 $5.3m716.8k shares
METTLER TOLEDO INTERNATIONAL MTD MTD 1,964 $2.5m2.0k shares
TESLA INC TSLA TSLA 5,177 $1.9m5.2k shares
TALEN ENERGY CORP TLN TLN 5,970 $1.9m6.0k shares
VISTRA CORP VST VST 6,000 $902.0k6.0k shares
ROBLOX CORP RBLX RBLX 8,420 $476.2k8.4k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 16,700 $326.7k16.7k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 950,000 $709.4m950.0k shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
BENITEC BIOPHARMA INC BNTC · 13D · filed 2025-11-10 BNTC 44.1%≈ $223.0m -5.8 pts 13D 2025-11-10
INFLARX NV IFRX · 13G · filed 2026-08-14 IFRX 15.6%≈ $27.8m +3.9 pts 13G 2026-08-14
MOLECULAR PARTNERS AG MOLN · 13G · filed 2025-05-02 MOLN 10.6% new 13G 2025-05-02
AADI BIOSCIENCE INC WHWK · 13G · filed 2025-03-11 WHWK 10.0%≈ $21.7m new 13G 2025-03-11
ZURA BIO LTD ZURA · 13G · filed 2026-05-12 ZURA 9.9%≈ $56.2m +1.3 pts 13G 2026-05-12
ARRIVENT BIOPHARMA INC AVBP · 13G · filed 2025-08-13 AVBP 9.9%≈ $118.6m 13G 2025-08-13
DBV TECHNOLOGIES S A DBVT · 13G · filed 2025-04-11 DBVT 9.9% new 13G 2025-04-11
KURA ONCOLOGY INC KURA · 13G · filed 2026-08-14 KURA 9.7%≈ $94.1m +0.3 pts 13G 2026-08-14
VERADERMICS INC MANE · 13D · filed 2026-08-21 MANE 8.8%≈ $457.2m -1.1 pts 13D 2026-08-21
IMMATICS N.V IMTX · 13G · filed 2026-02-13 IMTX 8.3%≈ $113.4m -1.6 pts 13G 2026-02-13
COMPASS THERAPEUTICS INC CMPX · 13G · filed 2025-08-21 CMPX 8.2%≈ $30.9m +3.0 pts 13G 2025-08-21
REPLIMUNE GROUP INC REPL · 13G · filed 2026-08-06 REPL 7.9%≈ $73.2m +2.8 pts 13G 2026-08-06
FAETH THERAPEUTICS INC FTH · 13G · filed 2026-06-23 FTH 7.8%≈ $50.5m new 13G 2026-06-23
BIOHAVEN LTD BHVN · 13G · filed 2026-02-13 BHVN 7.8%≈ $153.1m 13G 2026-02-13
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-04-13 LXEO 7.7%≈ $26.4m new 13G 2026-04-13
AURA BIOSCIENCES INC AURA · 13G · filed 2025-08-13 AURA 7.6%≈ $33.4m +1.5 pts 13G 2025-08-13
PALVELLA THERAPEUTICS INC NE PVLA · 13G · filed 2025-11-13 PVLA 7.4%≈ $125.7m -1.2 pts 13G 2025-11-13
CAPRICOR THERAPEUTICS INC CAPR · 13G · filed 2026-02-26 CAPR 6.6%≈ $82.3m new 13G 2026-02-26
AVALYN PHARMACEUTICALS INC AVLN · 13D · filed 2026-05-08 AVLN 5.6%≈ $82.4m new 13D 2026-05-08
89BIO INC ETNB · 13G · filed 2025-11-13 ETNB 5.6% -4.3 pts 13G 2025-11-13
FULCRUM THERAPEUTICS INC FULC · 13G · filed 2026-08-14 FULC 5.5%≈ $13.5m -3.9 pts 13G 2026-08-14
MARINUS PHARMACEUTICALS INC MRNS · 13G · filed 2025-02-11 MRNS 5.5% +1.7 pts 13G 2025-02-11

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-08-19 VERADERMICS INC Director · See footnotes MANE Sold 750,000 $80.4m750.0k shares -62%